ACVA

ACV Auctions Inc. Technology - Auto Marketplace Investor Relations →

YES
23.0% BELOW
↑ Moving away Was -48.3% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $13.51
14-Week RSI 76
Rel. Volume (14w) This week's trading vs. the 14-week average 7.4x — Surging
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 3.28 — Buyers winning

ACV Auctions Inc. (ACVA) closed at $10.41 as of 2026-09-11, trading 23.0% below its 200-week moving average of $13.51. This places ACVA in the extreme value zone. The stock moved further from the line this week, up from -48.3% last week. With a 14-week RSI of 76, ACVA is in overbought territory.

A big jump in activity this week — 7.4x the usual volume, and the price went up. Significantly more people than usual decided to buy. This kind of surge, especially on a stock already below its 200-week average, can be an early sign that sentiment is shifting.

Over the past 237 weeks of data, ACVA has crossed below its 200-week moving average 5 times. On average, these episodes lasted 30 weeks. Historically, investors who bought ACVA at the start of these episodes saw an average one-year return of +8.0%.

With a market cap of $1768 million, ACVA is a small-cap stock. The company generates a free cash flow yield of 0.1%. Return on equity stands at -15.1%. The stock trades at 4.5x book value.

Share count has increased 9.3% over three years, indicating dilution.

Over the past 4.7 years, a hypothetical investment of $100 in ACVA would have grown to $83, compared to $186 for the S&P 500. ACVA has returned -3.8% annualized vs 14.2% for the index, underperforming the broader market over this period.

In the past 12 months, corporate insiders have made 8 open-market purchases totaling $7,364,428. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while ACVA is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: ACVA vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After ACVA Crosses Below the Line?

Across 5 historical episodes, buying ACVA when it crossed below its 200-week moving average produced an average return of -9.6% after 12 months (median -2.0%), compared to +18.0% for the S&P 500 over the same periods. 40% of those episodes were profitable after one year. After 24 months, the average return was -11.7% vs +42.3% for the index.

Each line shows $100 invested at the moment ACVA crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. ACVA currently has negative free cash flow, so price-based dislocation levels are not available. The score still tracks yield deviation from baseline.

Current Bean Score +1.13σ
Current FCF Yield -0.39%
Baseline Yield -0.55%
Historical σ 0.83pp

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-08-10$0.05$0.06+19.4%
2026-05-06$0.03$0.04+32.4%
2026-02-23$-0.01$-0.01+49.1%
2025-11-05$0.06$0.07+8.6%
Data depth: 2 quarterly baselines, 23 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

12 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from ACVA's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation N/A Dividend yield vs own 10-yr norm
Drawdown Score +0.17σ Distance from line vs own history
Sector-Relative N/A Vs sector median this week
Buyback Acceleration +0.1pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity 92th TTM buys / market cap, percentile of buyers
FCF Yield vs History +1.5pp Vs own recent annual mean
Earnings Quality Improving Accrual gap trend (-5.0pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Insider Buying Activity

2 conviction buys in the past 12 months (purchases over $500K with meaningful position increases). 🔥 Cluster Buy Detected

DateInsiderTitleValueSharesPosition +%
2026-02-26WATERMAN MICHAEL GOfficer$1,000,036214,600+35.1%
2025-11-10GOODMAN ROBERT PDirector$5,118,609912,408+206.3%

Historical Touches

ACVA has crossed below its 200-week MA 5 times with an average 1-year return of +8.0% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Feb 2022May 20236265.9%-2.2%-16.7%
Sep 2023Nov 2023815.2%+42.2%-28.6%
Dec 2023Feb 20241112.7%+55.7%-27.5%
Mar 2025May 2025913.8%-63.7%-26.2%
Jul 2025Ongoing60+69.7%Ongoing-28.6%
Average30+8.0%

Frequently Asked Questions

Is ACVA below its 200-week moving average?

Yes. As of 2026-09-11, ACV Auctions Inc. (ACVA) is trading 23.0% below its 200-week moving average of $13.51. The current price is $10.41.

What is ACVA's 200-week moving average price?

ACV Auctions Inc.'s 200-week moving average is $13.51 as of 2026-09-11. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when ACVA drops below its 200-week moving average?

ACVA has crossed below its 200-week moving average 5 times in our data. On average, buying at that moment produced a one-year return of +8.0%. These dips have historically been decent entry points. These episodes lasted 30 weeks on average.

Is ACVA a good value right now?

Here's what our data says about ACVA as of 2026-09-11: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 76 (overbought). Free cash flow yield is 0.1%. Return on equity is -15.1%. Price-to-book is 4.5x. This is not a buy or sell recommendation — always do your own research.

How does ACVA compare to the S&P 500?

Over the past 4.7 years, $100 invested in ACVA would have grown to $83, compared to $186 for the S&P 500. That's -3.8% annualized vs 14.2% for the index. ACVA has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-09-11